Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon
Video Credit: HT Digital Content - Duration: 01:19s - Published
Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon
Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India.
Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.
![Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister [Video]](https://video.newsserve.net/300/v/20200930/2009301756-Covid-vaccine-Covaxin-phase-trials-on.jpg)
![UM Looking For Volunteers As Search For COVID Vaccine Enters Phase 3 Of Clinical Trials [Video]](https://video.newsserve.net/300/v/20200929/2009290321-UM-Looking-For-Volunteers-As-Search-For-COVID.jpg)
![UM Researchers Looking For Volunteers As They Enter Phase 3 Of COVID Vaccine Clinical Trials [Video]](https://video.newsserve.net/300/v/20200928/2009282327-UM-Researchers-Looking-For-Volunteers-As-They-Enter.jpg)
